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INTRODUCTION
Inflamma on is one of the most complex pathophysio-
logical processes involved in the host response to inju-
ry, whatever its intensity and origin [1]. Despite its ini-
al beneficial aspect (host defense) it can become ex-
cessive, either by reac ng to a non-injurious challenge
(allergies or autoimmunity) or by genera ng excessive
acute (shock or systemic inflammatory response syn-
drome) or long-las ng (chronic inflammatory diseases)
deleterious responses [2]. This beneficial/pathological
event involves a host of cellular effectors, redundant
humoral mediators and enzyme cascades whose im-
portance may vary depending on the nature of the trig-
ger [3]. Consequently, therapeu c interven ons in in-
flammatory diseases have a wide array of possible tar-
gets, notably phagocytes (par cularly polymorphonu-
clear neutrophils) and their products (oxidants, en-
zymes and cytokines) [4].
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Any drug which can prevent or suppress any or more of
the components of inflamma on are termed an -
inflammatory agents, plenty of drugs have flooded the
market. An -inflammatory drugs like NSAIDS will inhib-
it the cyclo-oxygenase pathway and the synthesis of
prostaglandins. Another group consis ng mainly of
steroidal an -inflammatory drugs exerts their ac on by
inhibi ng the enzyme phospholipase-A2. [5].
In the field of an bacterials, research is ongoing to im-
prove an bacterial profiles and to develop new thera-
peu c proper es, of which immunomodulatory an -
inflammatory ac vi es are at the leading edge. Obvi-
ously, an bacterial agents are primarily directed
against bacteria. However, because microorganisms
can ini ate an exaggerated inflammatory reac on, and
as pathogens which persist in cryp c reservoirs (cells or
granuloma ssue) can be the underlying cause of
chronic inflamma on, the hypothesis that an bacteri-
als can down regulate inflamma on by suppressing its
bacterial origin has held widespread support since the
beginning of an bio c therapy and s ll has strong ad-
vocates [6].
Among the an bacterial agents used in various inflam-
matory skin diseases, sulfonamides in the treatment of
Wegener's granulomatosis, and tetracyclines for in-
flammatory acne; the la er were first assessed in 1968
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to 1970 in rheumatoid arthri s (RA ) [7]. Rifampicin
were less effec ve in this disease, although Rifamycin
was beneficial in ankylosing spondyli s and juvenile RA.
It must be noted that all these agents impair phagocyte
func ons, and par cularly their potent oxidant-
genera ng system
Besides their an bacterial ac vity, some macrolides,
par cularly those derived from erythromycin are bene-
ficial in various clinical inflammatory se ngs, including
diffuse panbronchioli s (DPB) in Japanese pa ents and
cys c fibrosis (CF) its gene c counterpart in Caucasians,
asthma, atherosclerosis and lung cancer [8]. Although
the existence of an underlying intracellular pathogen,
genera ng chronic inflamma on has not been ruled
out in some diseases (eg,asthma and atherosclerosis),
there is some evidence that macrolides may modulate
inflammatory responses both in vitro and in vivo.
Aim: The present study was carried out to look for an -
inflammatory ac vity of ciprofloxacin and azithromycin
and comparison with standard an -inflammatory drug
Diclofenac sodium.
MATERIALS AND METHODS
Study design: An experimental animal based study
Ethics approval: The study was approved ins tu onal
ethics commi ee
Study loca on: Osmania Medical College, Hyderabad
Study dura on: 6 months
Inclusion criteria: Healthy adult mice weighing 20 – 30 g
and aged 6-8 weeks, were included in the present
study.
Raring of mice: Animal: The  animals  were  kept  in
wire  bo omed  cages  in  a  room  under  standard
condi on of  illumina on with a 12 - h  light-dark cycle
at 25 ± 1° C.
Sample size: In each group n=6
Grouping:
Group 1 (Control Group): administered normal saline
0.2 ml. i.p.
Group 2 (Standard Group): administered Diclofenac
sodium 25mg/kg i.p [9]
Group 3 (Test Group 1): administered Ciprofloxacin 50
mg/kg i.p [10]
Group 4 (Test Group 2): administered Azithromycin
20mg/kg i.p. [11]
Drugs prepara on:
1.Diclofenac Sodium (Tab. Voveran): Intraperitoneal
prepara on of Diclofenac sodium tablet 50mg was di-
luted with 20 ml of double dis lled water at room tem-
perature. The solu on was freshly prepared each me,
before/during experimental procedure. This solu on
has a concentra on of 2.5mg/ml.
2. Ciprofloxacin (Tab. Cifran): Intraperitoneal prepara-
on of Ciprofloxacin tablet 250mg was diluted with 30
ml of double dis lled water at room temperature. The
solu on was freshly prepared each me, before/during
experimental procedure. This solu on has a concentra-
on of 8.3mg/ml.
3. Azithromycin (Tab. Azax): Intraperitoneal prepara-
on of Azithromycin tablet 250mg was diluted with 50
ml of double dis lled water at room temperature. The
solu on was freshly prepared each me, before/during
experimental procedure. This solu on has a concentra-
on of 5mg/ml.
4. Carrageenan: 1% carrageenan administered to pro-
duce inflamma on
Study variables:
Independent variables: Diclofenac sodium, Ciprofloxa-
cin, Azithromycin
Dependent variables: Paw edema (Volume)
Procedure: A er 30 min of test drugs administra on
each group of mice were received subplantar admin-
istra on of 0.05ml of saline (Control) or 0.05ml carra-
geenan (1%) for test groups 2 to 4. An anatomical
marking is made at the level of malleolus of the right
hand paw of each animal in order to facilitate for dip-
ping in plethysmograph. Paw volumes were measured
by dipping in to the mercury plethysmograph at 30, 60,
120 and 180 minutes and results were tabulated. The
difference between the two readings at different inter-
vals indicates the actual edema. In this manner the
edema volumes was designated as Vc and Vt in the
control and drug treated group respec vely.
Percentage of inhibi on of edema [12] =Vc-Vt/Vc X 100
Sta s cal analysis: To analysis within the group at
different me interval t test was used and to compare
between the groups ANOVA was applied.
RESULTS
Table 1. Paw edema (ml) at different me intervals
Table 2. Percentage of inhibi on of edema in Mice
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Group
and Drugs
Paw edema (ml) at different me intervals
30 min 60 min 120 min 180 min
1: Normal
saline
0.14±0.02 0.08±0.02 0.07±0.01 0.04±0.02
2: Diclo-
fenac
sodium
0.08±0.02
**
0.02±0.01
**
0.02±0.01
**
0.02±0.01
3:
Ciproflox-
acin
0.10±0.01
*
0.04±0.02
*
0.04±0.01
*
0.02±0.01
4: Azithro-
mycin
0.12±0.01
$$
0.06±0.02
$$
0.06±0.02
$$
0.03±0.01
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DISCUSSION
In the present the mean percentage of mice paw ede-
ma inhibi on is more with Ciprofloxacin and are sta s-
cally significant at all- me intervals except at 180
minutes (P-value >0.05). The mean percentage of mice
paw edema inhibi on by Ciprofloxacin compared with
Diclofenac sodium. Here P-value not significant at all-
me intervals. The mean percentage of mice paw ede-
ma inhibi on by Azithromycin not sta s cally signifi-
cant at all- me intervals but less than Ciprofloxacin and
Diclofenac sodium.
Carrageenan works via the Bcl10, NF-κB, IκBα pathway
to ac vate inflamma on mediators. This pathway ini-
ally involves phosphoryla on steps followed by nucle-
ar transloca on of phospho-NF-κB.
Ciprofloxacin is also well known to have a posi ve im-
mune modula ng effect [13]. By posi ve immunomod-
ula ng effect it has an -inflammatory ac vity.
Ciprofloxacin augments the humoral and cellular im-
munity by a enua ng  the  proinflammatory  cytokines
such as TNF-alpha,  IL-1 beta, IL-4, IL-6, IL-8 and  IL-12
and s mula ng  the  an -inflammatory cytokines such
as IL-2,   IL-10, soluble TNF receptor 1&2, IL-1 receptor
antagonist and colony s mula ng factors [14].
Ciprofloxacin displays excellent ac vi es against nu-
merous respiratory tract pathogens. It is known to
strongly accumulate in human neutrophils and to easily
penetrate epithelial cells.
human nasal epithelial cells (HNECs). Inhibi on of the IL
-8 response by ciprofloxacin could be a ributed to im-
munomodulatory effects [15].
fluorquinolones with a cyclopropyl-moiety at posi on
N1 like ciprofloxacin and moxifloxacin expression of pro
-inflammatory cytokines in human monocytes is sup-
pressed by moxifloxacin in vitro and in vivo [16].  The
macrolides have long been associated with an -
inflammatory benefits in pa ents with chronic pulmo-
nary inflammatory disorders. Mul ple in vitro and in
vivo an -inflammatory effects respiratory tract of bron-
chioli s pa ents [8].  Macrolides like Azithromycin have
been shown to affect a number of the processes in-
volved in inflamma on, including the migra on of neu-
trophils, the oxida ve burst in phagocytes and the pro-
duc on of various cytokines. According to Amsden etal
These effects have been linked to the ability of macro-
lides to accumulate in mammalian cells (play an im-
portant role in their an -inflammatory ac vity as poly-
morphonuclear lymphocytes also contribute to inflam-
ma on and ssue damage).The macrolides have long
been associated with an -inflammatory benefits in
pa ents with chronic pulmonary inflammatory disor-
ders [17].
Macrolids like zithromycin inhibited arachidonic acid
release in the same way as a cPLA₂ inhibitor, while in-
domethacin had no effect. Further comparison re-
vealed that in LPS-s mulated J774A.1 cells, the cPLA₂
inhibitor showed the same profile of inhibi on as
azithromycin in inhibi ng PGE₂, IL-6, IL-12p40 and ara-
chidonic acid release [18].
CONCLUSION
In conclusion it may be said that Ciprofloxacin (50mg/
kg) has exhibited consistent an -inflammatory, but the
an -inflammatory ac vity of is less than that of Diclo-
fenac sodium (25mg/kg) and  Azithromycin (20mg/kg)
also has exhibited an -inflammatory ac vity, though
much less when compared to Diclofenac sodium
(25mg/kg) and Ciprofloxacin (50mg/kg).
Limita ons: The Ciprofloxacin and Azithromycin are
well-tolerated an microbial agents. Although their an
-inflammatory ac vity is secondary to an -infec ve
capacity, these results suggest that further work should
be conducted to inves gate the mechanism of these
effects.
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